Schering-Plough buys $14B Organon (CNN.com)
AMSTERDAM, Netherlands (Reuters) -- Akzo Nobel said on Monday it was selling its drugs unit Organon BioSciences to Schering-Plough for 11 billion euros ($14.4 billion), in a last-minute reversal of plans to float it on the stock market.

Schering-Plough to buy Akzo's Organon for $14.5 bln (Reuters via Yahoo! News)
Akzo Nobel said on Monday it was selling its drugs unit Organon BioSciences to Schering-Plough for 11 billion euros ($14.5 billion), dropping plans to float it in a public share offering.

Schering-Plough, Organon in $14B deal (CNN Money)
Deal valued at $14 billion, priced over market expectations, seen as giving U.S. drugmaker heft.